Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Levels and Initial Course of Serum Alanine Aminotransferase Can Predict Outcome of Patients With Budd-Chiari Syndrome
Clinical Gastroenterology and Hepatology , 11/05/09
Rautou PE et al. – Determination of ALT levels at patient presentation allows 2 variants of Budd–Chiari syndrome to be distinguished. High levels of ALT reflect acute, severe, but potentially reversible, ischemic liver cell necrosis. High levels of ALT that decrease slowly predict a poor outcome for patients and might justify rapid aggressive management.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Joint Extraintestinal Manifestations in Ulcerative Colitis
Digestive Diseases, 11/09/09
The liver in 30-year-old individuals with alpha 1 -antitrypsin deficiency
Scandinavian Journal of Gastroenterology, 11/06/09
Caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease
Alimentary Pharmacology and Therapeutics, 11/03/09
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Liver disease: Early signs you may be missing
APCToday, 10/21/09
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09
Severe sepsis in cirrhosis
Hepatology, 11/04/09
Sponsor
Article Search
Sponsor


See All



